NEW YORK (GenomeWeb) – T2 Biosystems said today that it has received CE marking for its T2Bacteria Panel, enabling the sale and distribution of the product within the European Union countries and others accepting the mark.

The bacteria panel will be commercially available as part of the T2Sepsis Solution in Europe in the third quarter of 2017, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.